Buspirone for the treatment of anxiety in Williams syndrome: a retrospective chart review study

References

• Strømme P, Bjømstad PG, Ramstad K. Prevalence estimation of Williams syndrome. J Child Neurol [Internet]. 2002 [cited 2019 Jan 23];17(4):269–271. doi: 10.1177/088307380201700406
   PubMed Web of Science ®Google Scholar
• Kozel BA, Barak B, Kim CA, et al. Williams syndrome [Internet]. Nat Rev Dis Prim. 2021. [cited 2021 Oct 19];7(1). doi: 10.1038/s41572-021-00276-z
   PubMed Web of Science ®Google Scholar
• Bellugi U, Lichtenberger L, Jones W, et al. I. The neurocognitive profile of Williams syndrome: a complex pattern of strengths and weaknesses [internet]. J Cogn Neurosci 2000 [cited 2020 Jul 16];12:7–29. doi: 10.1162/089892900561959
   PubMed Web of Science ®Google Scholar
• Mervis CB, John AE. Cognitive and behavioral characteristics of children with Williams syndrome: implications for intervention approaches. American J Of Med Genetics Pt C. 2010. [cited 2020 Jul 16];154(2):229–248. doi: 10.1002/ajmg.c.30263
   Google Scholar
• Royston R, Howlin P, Waite J, et al. Anxiety disorders in Williams syndrome contrasted with intellectual disability and the general population: a systematic review and meta-analysis. J Autism Dev Disord [Internet]. 2017 [cited 2019 Nov 21];47(12):3765–3777. doi: 10.1007/s10803-016-2909-z
   PubMed Web of Science ®Google Scholar
• Leyfer OT, Woodruff-Borden J, Klein-Tasman BP, et al. Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome. Am J Med Genet Part B Neuropsychiatr Genet [Internet] 2006 [cited 2019 Sep 29];141B:615–622. doi: 10.1002/ajmg.b.30344
   PubMed Web of Science ®Google Scholar
• Klein-Tasman B, Young B, Levine K, et al. Acceptability and effectiveness of humor- and play-infused exposure therapy for fears in Williams syndrome. Evidence-Based Pract Child Adolesc Ment Heal. 2022;7(1):94–111. doi: 10.1080/23794925.2021.1950080
   Google Scholar
• Thom RP, Pober BR, McDougle CJ. Psychopharmacology of Williams syndrome: safety, tolerability, and effectiveness [internet]. Expert Opin Drug Saf. 2021 [cited 2021 Feb 8];20(3):293–306. Available from: https://pubmed.ncbi.nlm.nih.gov/33369485/
   PubMed Web of Science ®Google Scholar
• Riby DM, Hanley M, Kirk H. et al. The interplay between anxiety and social functioning in Williams syndrome. J Autism Dev Disord [Internet]. 2014 [cited 2020 Jul 16];44(5):1220–1229. doi: 10.1007/s10803-013-1984-7
   PubMed Web of Science ®Google Scholar
• Davies M, Udwin O, Howlin P. Adults with Williams syndrome: preliminary study of social, emotional and behavioural difficulties. Br J Psychiatry [Internet]. 1998. [cited 2020 Jul 16];172(3):273–276. doi: 10.1192/bjp.172.3.273
   PubMedGoogle Scholar
• Ng-Cordell E, Hanley M, Kelly A. et al. Anxiety in Williams syndrome: the role of social behaviour, executive functions and change over time. J Autism Dev Disord [Internet]. 2018 [cited 2019 Sep 29];48(3):796–808. doi: 10.1007/s10803-017-3357-0
   PubMed Web of Science ®Google Scholar
• Thom R, Pineda J, Nowinski L, et al. A virtually delivered adapted cognitive behavioral therapy group for adults with Williams syndrome and anxiety. Cogn Behav Pract. 2022;30(4):669–677. doi: 10.1016/j.cbpra.2022.02.025
   Web of Science ®Google Scholar
• Miodrag N, Lense M, Dykens E. A pilot study of a mindfulness intervention for individuals with Williams syndrome: physiological outcomes. Mindfulness (NY). 2013;4(2):137–147. doi: 10.1007/s12671-012-0178-2
   Web of Science ®Google Scholar
• Green T, Avda S, Dotan I, et al. Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment. Am J Med Genet Part B Neuropsychiatr Genet. 2012;159B(1):13–20. doi: 10.1002/ajmg.b.31247
   PubMed Web of Science ®Google Scholar
• Thom RP, Keary CJ, Waxler JL. et al. Buspirone for the treatment of generalized anxiety disorder in Williams syndrome: a case series. J Autism Dev Disord [Internet]. 2020 [cited 2020 Jun 24];50(2):676–682. doi: 10.1007/s10803-019-04301-9
   PubMed Web of Science ®Google Scholar
• Schatzberg A, DeBattista C. Manual of clinical psychopharmacology. 8th ed. Arlington (VA): American Psychiatric Publishing, Inc.; 2015
   Google Scholar
• Bergman J, Roof RA, Furman CA, et al. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol. 2013;16(2):445–458. doi: 10.1017/S1461145712000661
   PubMed Web of Science ®Google Scholar
• Le Foll B, Payer D, Di Ciano P, et al. Occupancy of dopamine D3 and D2 receptors by buspirone: a [11C]-(+)-PHNO PET study in humans. Neuropsychopharmacol [Internet]. 2016 [cited 2023 Sep 13];41(2):529–537. doi: 10.1038/npp.2015.177
   PubMed Web of Science ®Google Scholar
• Feighner JP, Merideth CH, Hendrickson GA. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J Clin Psychiatry [Internet]. 1982 [cited 2019 Jan 24];43:103–108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6130066
   PubMed Web of Science ®Google Scholar
• Pecknold JC, Matas M, Howarth BG. et al. Evaluation of Buspirone as an Antianxiety Agent: Buspirone and Diazepam versus Placebo. Can J Psychiatry [Internet]. 1989 [cited 2019 Jan 24];34(8):766–771. doi: 10.1177/070674378903400804
   PubMed Web of Science ®Google Scholar
• Sramek JJ, Frackiewicz EJ, Cutler NR. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety. Clinical Therapeutics. 1997. [cited 2022 Jan 31];19(3):498–506. doi: 10.1016/S0149-2918(97)80134-8
   PubMed Web of Science ®Google Scholar
• Martens MA, Seyfer DL, Andridge RR, et al. Parent report of antidepressant, anxiolytic, and antipsychotic medication use in individuals with Williams syndrome: effectiveness and adverse effects. Res Dev Disabil [Internet]. 2012 [cited 2020 Jul 16];33(6):2106–2121. doi: 10.1016/j.ridd.2012.06.006
   PubMed Web of Science ®Google Scholar
• Ceranoglu TA, Wozniak J, Fried R. et al. A retrospective chart review of buspirone for the treatment of anxiety in psychiatrically referred youth with high-functioning autism spectrum disorder. J Child Adolesc Psychopharmacol [Internet]. 2019 [cited 2020 Jun 22];29(1):28–33. doi: 10.1089/cap.2018.0021
   PubMed Web of Science ®Google Scholar
• Buitelaar JK, Van Der Gaag RJ, Van Der Hoeven J. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 1998;59:56–59. doi: 10.4088/JCP.v59n0203
   PubMed Web of Science ®Google Scholar
• Strawn JR, Mills JA, Cornwall GJ. et al. Buspirone in children and adolescents with anxiety: a review and bayesian analysis of abandoned randomized controlled trials. J Child Adolesc Psychopharmacol [Internet]. 2018 [cited 2023 Sep 13];28(1):2–9. doi: 10.1089/cap.2017.0060
   PubMed Web of Science ®Google Scholar
• Company B-MS. Buspar.
   Google Scholar
• Newton R, Marunycz J, Marc Alderdice M, et al. Review of the side-effect profile of buspirone. Am J Med. 1986;80(3):17–21. doi: 10.1016/0002-9343(86)90327-X
   PubMedGoogle Scholar
• Pober BR, Morris CA. Diagnosis and management of medical problems in adults with Williams–Beuren syndrome. American J Of Med Genetics Pt C. 2007. [cited 2020 Jul 16];145C(3):280–290. doi: 10.1002/ajmg.c.30139
   PubMed Web of Science ®Google Scholar